Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,566,494
  • Shares Outstanding, K 57,339
  • Annual Sales, $ 661,820 K
  • Annual Income, $ 73,870 K
  • EBIT $ 46 M
  • EBITDA $ 128 M
  • 60-Month Beta 0.71
  • Price/Sales 3.82
  • Price/Cash Flow 10.58
  • Price/Book 2.41

Options Overview Details

View History
  • Implied Volatility 36.01% (-1.55%)
  • Historical Volatility 61.60%
  • IV Percentile 12%
  • IV Rank 21.98%
  • IV High 79.59% on 01/30/25
  • IV Low 23.73% on 06/11/25
  • Expected Move (DTE 15) 2.47 (5.47%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 167
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 3,294
  • Open Int (30-Day) 4,009
  • Expected Range 42.64 to 47.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.15
  • Number of Estimates 1
  • High Estimate 0.15
  • Low Estimate 0.15
  • Prior Year 0.61
  • Growth Rate Est. (year over year) -75.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.11 +4.62%
on 11/05/25
51.51 -12.44%
on 11/05/25
-11.90 (-20.88%)
since 11/04/25
3-Month
43.11 +4.62%
on 11/05/25
57.65 -21.77%
on 10/30/25
-0.33 (-0.73%)
since 09/04/25
52-Week
29.16 +54.66%
on 05/07/25
57.65 -21.77%
on 10/30/25
+7.95 (+21.40%)
since 12/04/24

Most Recent Stories

More News
3 Unprofitable Stocks We Find Risky

3 Unprofitable Stocks We Find Risky

AAP : 52.50 (-1.92%)
SUPN : 45.10 (+0.76%)
CNC : 38.85 (+0.10%)
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference

ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 45.10 (+0.76%)
1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

COO : 77.03 (+1.38%)
SUPN : 45.10 (+0.76%)
HCA : 487.66 (+0.18%)
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference

ROCKVILLE, Md., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 45.10 (+0.76%)
Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

SUPN : 45.10 (+0.76%)
3 Russell 2000 Stocks Walking a Fine Line

3 Russell 2000 Stocks Walking a Fine Line

LMAT : 85.70 (+0.92%)
SUPN : 45.10 (+0.76%)
WNC : 9.24 (+1.99%)
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London

ROCKVILLE, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 45.10 (+0.76%)
5 Must-Read Analyst Questions From Supernus Pharmaceuticals’s Q3 Earnings Call

5 Must-Read Analyst Questions From Supernus Pharmaceuticals’s Q3 Earnings Call

SUPN : 45.10 (+0.76%)
Why Supernus Pharmaceuticals (SUPN) Shares Are Trading Lower Today

Why Supernus Pharmaceuticals (SUPN) Shares Are Trading Lower Today

SUPN : 45.10 (+0.76%)
SUPN Q3 Deep Dive: Growth Drivers Offset By Supply Constraints and Integration Costs

SUPN Q3 Deep Dive: Growth Drivers Offset By Supply Constraints and Integration Costs

SUPN : 45.10 (+0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 46.19
2nd Resistance Point 45.65
1st Resistance Point 45.37
Last Price 45.10
1st Support Level 44.55
2nd Support Level 44.01
3rd Support Level 43.73

See More

52-Week High 57.65
Fibonacci 61.8% 46.77
Last Price 45.10
Fibonacci 50% 43.40
Fibonacci 38.2% 40.04
52-Week Low 29.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar